Delivery Order SPE2DE24D0013-SPE2D625F0VGB
- Not listed
- The U.S. Defense Logistics Agency (DLA), operating through its Medical Supply Chain division, awarded a $28,786 firm fixed-price delivery order to Cepheid Inc. on September 4, 2025, with completion scheduled for September 11, 2025. This non-set-aside contract is issued under Cepheid's existing Indefinite Delivery Vehicle (IDV) with the Veterans Integrated Service Network (VISN) 6, a $32.8 million single-award contract that extends through September 30, 2030. The work will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a firm fixed-price delivery order valued at $1,843.36 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The contract, issued on September 18, 2025, with an ultimate completion date of September 25, 2025, carries no set-aside designation. The delivery order will be performed in Sunnyvale and represents a continuation of Cepheid's ongoing provision of diagnostic equipment,...
- The Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $1,190.28 to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions based in Sunnyvale, California. This firm fixed-price delivery order, issued on June 6, 2025, with an ultimate completion date of June 23, 2025, carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of diagnostic testing solutions to federal defense and healthcare...
- The U.S. Defense Logistics Agency (Medical Supply Chain) awarded a firm fixed-price delivery order valued at $3,708.00 to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California. The delivery order, issued on September 5, 2025, with an ultimate completion date of September 12, 2025, carries no set-aside designation. This award represents a discrete delivery order under one of Cepheid's larger indefinite delivery vehicle contracts with the...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $1,800 firm fixed-price delivery order to Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California. This delivery order, issued on August 25, 2025, with an ultimate completion date of September 2, 2025, carries no set-aside designation and represents a continuation of the agency's procurement of advanced diagnostic solutions. The work will be performed at Cepheid's Sunnyvale facility....
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $27,650.40 firm fixed-price delivery order to Cepheid Inc. on September 18, 2025, with completion targeted for September 25, 2025. The delivery order, identified as XPRSMVP-10 (Contract Number 4569505244), is being performed at Cepheid's headquarters in Sunnyvale, California. This award carries no set-aside designation and represents a discrete procurement under the company's broader federal contracting relationship with...
- Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $5,440 on September 5, 2025, by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The delivery order, identified as XPCOV2/FLU/RSV-10, is structured as a firm fixed-price contract with no set-aside designation and calls for completion by September 12, 2025. Based on the contract nomenclature and Cepheid's product portfolio, this delivery order...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, received a firm fixed-price delivery order valued at $1,190.28 from the Defense Logistics Agency (DLA), which operates under the Medical Supply Chain function. The contract, awarded on September 11, 2025, with an ultimate completion date of September 25, 2025, carries no set-aside designation. This delivery order is executed under a larger indefinite delivery vehicle (IDV) contract structure, enabling...
- The U.S. Defense Logistics Agency, through the Medical Supply Chain division, awarded a $4,080 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on June 18, 2025, with an ultimate completion date of June 26, 2025, is designated as XPCOV2/FLU/RSV-10 and carries no set-aside designation. The delivery order addresses federal requirements for COVID-19, influenza, and respiratory syncytial virus...
- This delivery order, issued on July 28, 2025, awards Cepheid Inc. a firm fixed-price contract valued at $1,190.28 for molecular diagnostic solutions under a Defense Logistics Agency Medical Supply Chain program. The contract is set to be completed by August 11, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. The award reflects the company's established role as a key supplier of diagnostic systems and reagents to federal defense and healthcare agencies,...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F0VGBDelivery Order
The Defense Logistics Agency (DLA), under the Medical Supply Chain program, awarded a delivery order valued at $1,648.38 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on August 12, 2025. This firm fixed-price delivery order, without set-aside designation, represents a continuation of Cepheid's ongoing provision of diagnostic testing solutions to federal defense and healthcare agencies. The contract is scheduled for ultimate completion by August 19, 2025, with performance occurring at Cepheid's Sunnyvale facility. Cepheid specializes in GeneXpert diagnostic systems and molecular reagent kits used across federal healthcare networks for detecting infectious diseases including COVID-19, influenza, RSV, and other clinical conditions. This delivery order likely represents a continuation purchase under one of Cepheid's existing Indefinite Delivery/Indefinite Quantity (IDIQ) contracts, such as the $32.8 million Veterans Integrated Service Network 6 IDV or the $2.5 million Veterans Integrated Service Network 21 PCR testing vehicle, both of which provide ongoing procurement authority for molecular diagnostic reagents and testing services through fiscal year 2030. Cepheid's established federal contracting presence with the Veterans Affairs system, Defense Health Agency, and Defense Logistics Agency demonstrates its competitive positioning as a critical supplier of diagnostic technologies to federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/12/25 |